Rare diseases
Investigational molecules
Locations
347 conditions with trials, the busiest first
973 trials across Europe, recruiting first
Study of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer
BelgiumA study comparing furazidin and clindamycin for women with bacterial vaginosis
CzechiaStudy of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing
BelgiumStudy on the Safety and Effectiveness of Trastuzumab Deruxtecan vs. Palbociclib-Based Drug Combination for Advanced HR-Positive, HER2-Low Breast Cancer Patients
AustriaStudy on the Effectiveness of GP2 and Sargramostim for HER2 Positive Breast Cancer Patients with Residual Disease or High-Risk After Standard Therapy
AustriaStudy of Tersolisib and a drug combination for adults with advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
BelgiumShort-course (7‑day) versus standard 14‑day ciprofloxacin treatment for men with serious urinary tract infection
BelgiumEvaluation of pembrolizumab and bevacizumab in patients with metastatic cervical cancer
The NetherlandsA study to evaluate the effectiveness of methotrexate in preventing the recurrence of dermatological vulvar intraepithelial neoplasia in women with lichen sclerosus.
The NetherlandsA study to evaluate the effect of valproic acid in women of reproductive age with adenomyosis
BulgariaA study of tirzepatide and levonorgestrel in women with endometrial cancer
IrelandStudy on Atorvastatin's Role in Enhancing Immunotherapy for Patients with Triple Negative Breast Cancer and Non-Small Cell Lung Cancer
ItalyThe therapies tested most often in Reproductive system and breast disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
